We are live on ! Find out more
IART icon

Integra LifeSciences

259 hedge funds and large institutions have $3.96B invested in Integra LifeSciences in 2019 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 100 increasing their positions, 80 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

31% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 36

25% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 80

23% more capital invested

Capital invested by funds: $3.23B → $3.96B (+$731M)

4% more funds holding

Funds holding: 248259 (+11)

0.56% less ownership

Funds ownership: 83.99%83.43% (-0.56%)

58% less call options, than puts

Call options by funds: $7.84M | Put options by funds: $18.5M

Holders
259
Holders Change
+11
Holders Change %
+4.44%
% of All Funds
5.61%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
47
Increased
100
Reduced
80
Closed
36
Calls
$7.84M
Puts
$18.5M
Net Calls
-$10.6M
Net Calls Change
-$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
ERSOT
101
Employees Retirement System of Texas
Texas
$1.84M -$153K -3,000 -8%
Morgan Stanley
102
Morgan Stanley
New York
$1.78M -$9.92M -194,831 -86%
UBS Group
103
UBS Group
Switzerland
$1.77M -$36.6K -718 -2%
AG
104
Advisor Group
Arizona
$1.72M +$14.4K +282 +0.9%
WB
105
WesBanco Bank
West Virginia
$1.66M
Treasurer of the State of North Carolina
106
Treasurer of the State of North Carolina
North Carolina
$1.66M +$12.1K +237 +0.8%
OPERF
107
Oregon Public Employees Retirement Fund
Oregon
$1.57M +$22.6K +444 +2%
GC
108
Guggenheim Capital
Illinois
$1.51M +$228K +4,467 +20%
CSS
109
Cubist Systematic Strategies
Connecticut
$1.5M -$488K -9,581 -26%
T. Rowe Price Associates
110
T. Rowe Price Associates
Maryland
$1.48M +$6.62K +130 +0.5%
Barclays
111
Barclays
United Kingdom
$1.47M -$831K -16,318 -38%
SCM
112
Stevens Capital Management
Pennsylvania
$1.41M +$1.29M +25,359 New
SOMRS
113
State of Michigan Retirement System
Michigan
$1.4M
Asset Management One
114
Asset Management One
Japan
$1.37M +$191K +3,749 +18%
Nisa Investment Advisors
115
Nisa Investment Advisors
Missouri
$1.37M
Federated Hermes
116
Federated Hermes
Pennsylvania
$1.31M -$78.6K -1,543 -6%
MLICM
117
Metropolitan Life Insurance Company (MetLife)
New York
$1.28M -$4.43K -87 -0.4%
Balyasny Asset Management
118
Balyasny Asset Management
Illinois
$1.19M +$1.08M +21,264 New
Deutsche Bank
119
Deutsche Bank
Germany
$1.18M -$5.9M -115,868 -84%
MAM
120
Martingale Asset Management
Massachusetts
$1.17M -$1.37M -26,903 -56%
AIP
121
Ameritas Investment Partners
Nebraska
$1.16M
First Trust Advisors
122
First Trust Advisors
Illinois
$1.15M -$27.1M -531,876 -96%
CT
123
Cambridge Trust
Massachusetts
$1.09M -$21.5K -422 -2%
VRS
124
Virginia Retirement Systems
Virginia
$1.07M +$25.5K +500 +3%
VOYA Investment Management
125
VOYA Investment Management
Georgia
$1.07M -$58.1K -1,140 -6%

IART Hedge Fund Activity: Q1 2019 in Review

259 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2019, worth a combined $3.96B — up 23% from $3.23B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new IART positions and 36 closed out — a net gain of 11 holders — while 100 added to existing stakes and 80 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $35.1M. The largest seller was Fidelity Investments, cutting an estimated $77.3M.

  • 259 institutional investors held Integra LifeSciences (IART) as of Q1 2019, up from 248 in Q4 2018.
  • Funds reported $3.96B of Integra LifeSciences stock for Q1 2019, up 23% quarter-over-quarter.
  • 47 funds opened new Integra LifeSciences positions in Q1 2019 and 36 closed out, a net change of +11 holders.
  • The largest Integra LifeSciences buyer in Q1 2019 was Janus Henderson Group, an estimated $35.1M added.
  • The largest Integra LifeSciences seller in Q1 2019 was Fidelity Investments, an estimated $77.3M sold.

Based on aggregated 13F filings for Q1 2019.